Search research articles
Contact Us
Filters
Showing results (51-60 of 69) with videos related to
Page
of 7
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
January 31, 2013
¹⁸F-FDG PET SUVmax as an indicator of histopathologic response after neoadjuvant chemotherapy in extremity osteosarcoma
Chang-Bae Kong, Byung Hyun Byun, Ilhan Lim, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 22, 2014
Early response monitoring to neoadjuvant chemotherapy in osteosarcoma using sequential ¹⁸F-FDG PET/CT and MRI
Byung Hyun Byun, Chang-Bae Kong, Ilhan Lim, et al.
Nuclear Medicine and Molecular Imaging
|
March 17, 2015
The Role of (18)F-FDG PET/CT as a Prognostic Factor in Patients with Synovial Sarcoma
Kyoung Jin Chang, Ilhan Lim, Joon Yeun Park, et al.
Annals of Nuclear Medicine
|
May 24, 2013
A new method for apparent diffusion coefficient measurement using sequential (18)F-FDG PET and MRI: correlation with histological grade of invasive ductal carcinoma of the breast
Byung Hyun Byun, Woo Chul Noh, Ilhan Lim, et al.
Scientific Reports
|
December 4, 2020
Early prediction of neoadjuvant chemotherapy response for advanced breast cancer using PET/MRI image deep learning
Joon Ho Choi, Hyun-Ah Kim, Wook Kim, et al.
Clinical Nuclear Medicine
|
May 25, 2021
A Phase 0 Microdosing PET/CT Study Using O-[18F]Fluoromethyl-d-Tyrosine in Normal Human Brain and Brain Tumor
Hansol Moon, Byung Hyun Byun, Ilhan Lim, et al.
Nuclear Medicine and Molecular Imaging
|
August 20, 2016
The Relationship Between Estrogen Receptor, Progesterone Receptor and Human Epidermal Growth Factor Receptor 2 Expression of Breast Cancer and the Retention Index in Dual Phase (18)F-FDG PET/CT
Hansol Moon, Woo Chul Noh, Hyun-Ah Kim, et al.
Cancer Chemotherapy and Pharmacology
|
February 2, 2013
Repeated radioimmunotherapy with 131I-rituximab for patients with low-grade and aggressive relapsed or refractory B cell non-Hodgkin lymphoma
Hye Jin Kang, Seung-Sook Lee, Byung Hyun Byun, et al.
Clinical Medicine Insights. Oncology
|
December 13, 2023
A Phase II Study of <sup>131</sup>I-rituximab for Patients With Relapsed or Refractory Marginal Zone Lymphoma
Yoon Jung Jang, Sang Moo Lim, Inki Lee, et al.
EJNMMI Research
|
January 21, 2021
A preliminary clinical trial to evaluate <sup>64</sup>Cu-NOTA-Trastuzumab as a positron emission tomography imaging agent in patients with breast cancer
Inki Lee, Ilhan Lim, Byung Hyun Byun, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 69) with videos related to
Sort By:
Page
of 7
European Journal of Nuclear Medicine and Molecular Imaging
|
January 31, 2013
¹⁸F-FDG PET SUVmax as an indicator of histopathologic response after neoadjuvant chemotherapy in extremity osteosarcoma
Chang-Bae Kong, Byung Hyun Byun, Ilhan Lim, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 22, 2014
Early response monitoring to neoadjuvant chemotherapy in osteosarcoma using sequential ¹⁸F-FDG PET/CT and MRI
Byung Hyun Byun, Chang-Bae Kong, Ilhan Lim, et al.
Nuclear Medicine and Molecular Imaging
|
March 17, 2015
The Role of (18)F-FDG PET/CT as a Prognostic Factor in Patients with Synovial Sarcoma
Kyoung Jin Chang, Ilhan Lim, Joon Yeun Park, et al.
Annals of Nuclear Medicine
|
May 24, 2013
A new method for apparent diffusion coefficient measurement using sequential (18)F-FDG PET and MRI: correlation with histological grade of invasive ductal carcinoma of the breast
Byung Hyun Byun, Woo Chul Noh, Ilhan Lim, et al.
Scientific Reports
|
December 4, 2020
Early prediction of neoadjuvant chemotherapy response for advanced breast cancer using PET/MRI image deep learning
Joon Ho Choi, Hyun-Ah Kim, Wook Kim, et al.
Clinical Nuclear Medicine
|
May 25, 2021
A Phase 0 Microdosing PET/CT Study Using O-[18F]Fluoromethyl-d-Tyrosine in Normal Human Brain and Brain Tumor
Hansol Moon, Byung Hyun Byun, Ilhan Lim, et al.
Nuclear Medicine and Molecular Imaging
|
August 20, 2016
The Relationship Between Estrogen Receptor, Progesterone Receptor and Human Epidermal Growth Factor Receptor 2 Expression of Breast Cancer and the Retention Index in Dual Phase (18)F-FDG PET/CT
Hansol Moon, Woo Chul Noh, Hyun-Ah Kim, et al.
Cancer Chemotherapy and Pharmacology
|
February 2, 2013
Repeated radioimmunotherapy with 131I-rituximab for patients with low-grade and aggressive relapsed or refractory B cell non-Hodgkin lymphoma
Hye Jin Kang, Seung-Sook Lee, Byung Hyun Byun, et al.
Clinical Medicine Insights. Oncology
|
December 13, 2023
A Phase II Study of <sup>131</sup>I-rituximab for Patients With Relapsed or Refractory Marginal Zone Lymphoma
Yoon Jung Jang, Sang Moo Lim, Inki Lee, et al.
EJNMMI Research
|
January 21, 2021
A preliminary clinical trial to evaluate <sup>64</sup>Cu-NOTA-Trastuzumab as a positron emission tomography imaging agent in patients with breast cancer
Inki Lee, Ilhan Lim, Byung Hyun Byun, et al.
Page
of 7